Serum from patients with hepatitis E virus-related acute liver failure induces human liver cell apoptosis

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 300-304

  Wu, Fan ^a   Wang, Minxin ^a   Tian, Deying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute liver failure; Apoptosis; Core polysaccharide; Serum

Indexed keywords

ENDOTOXIN;

ADULT; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; LIVER FAILURE; MALE; SPECTROPHOTOMETRY;

EID: 84887951693     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1398     Document Type: Article

References (35)

1. Lee WM: Acute liver failure. Semin Respir Crit Care Med 33: 36-45, 2012.
2. Mas A and Rodés J: Fulminant hepatic failure. Lancet 349: 1081-1085, 1997.
3. Macnaughtan J and Thomas H: Liver failure at the front door. Clin Med 10: 73-78, 2010.
4. Neuberger J: Prediction of survival for patients with fulminant hepatic failure. Hepatology 41: 19-22, 2005.
5. Bernal W, Auzinger G, Dhawan A and Wendon J: Acute liver failure. Lancet 376: 190-201, 2010.
6. Tanaka Y, Takahashi K, Orito E, et al: Molecular tracing of Japan-indigenous hepatitis E viruses. J Gen Virol 87: 949-954, 2006.
7. Li TC, Chijiwa K, Sera N, et al: Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 11: 1958-1960, 2005.
8. Chau TN, Lai ST, Tse C, et al: Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 101: 292-296, 2006.
9. Togo S, Kubota T, Matsuo K, et al: Mechanism of liver failure after hepatectomy. Nihon Geka Gakkai Zasshi 105: 658-663, 2004 (In Japanese).
10. Pathil A, Warth A, Chamulitrat W and Stremmel W: The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury. J Hepatol 54: 674-684, 2011.
11. McCloskey P, Tootle R, Selden C, Larsen F, Roberts E and Hodgson HJ: Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs 26: 340-348, 2002.
12. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J and Williams R: The systemic inflammatory response syndrome in acute liver failure. Hepatology 32: 734-739, 2000.
13. Rolando N, Harvey F, Brahm J, et al: Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 11: 49-53, 1990.
14. Vaquero J, Polson J, Chung C, et al: Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology125: 755-764, 2003.
15. Kamimoto M, Mizuno S and Nakamura T: Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia. Int J Mol Med 24: 161-170, 2009.
16. McAvoy EF, McDonald B, Parsons SA, Wong CH, Landmann R and Kubes P: The role of CD14 in neutrophil recruitment within the liver microcirculation during endotoxemia. J Immunol 186: 2592-2601, 2011.
17. Raulf-Heimsoth M, Liebers V and Brüning T: Mechanism of endotoxin action and pattern of diseases. Gefahrstoffe Reinhaltung Der Luft 67: 351-353, 2007 (In German).
18. Li T, Hu J, Thomas JA and Li L: Differential induction of apoptosis by LPS and taxol in monocytic cells. Mol Immunol 42: 1049-1055, 2005.
19. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, EddlestonAL and Williams R: Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2: 72-74, 1988.
20. Jalan R, Olde Damink S, Hayes PC, Deutz NEP and Lee A: Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41: 613-620, 2004.
21. Han DW: Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 8: 961-965, 2002.
22. Warren HS, Amato SF, Fitting C, et al: Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 177: 89-97, 1993.
23. Newsome PN, Tsiaoussis J, Masson S, et al: Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 40: 636-645, 2004.
24. Du WB, Pan XP, Yu XP, et al: Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes. Hepatobiliary Pancreat Dis Int9: 611-614, 2010.
25. Chen M, Zhou J, Li H, Chen A, Zhang Z and Tian D: Effects of endotoxin on liver Smac apoptosis channel. J Huazhong Univ Sci Technolog Med Sci 28: 660-664, 2008.
26. Nie B, Park HM, Kazantzis M, et al: Specific bile acids inhibit hepatic fatty acid uptake in mice. Hepatology 56: 1300-1310, 2012.
27. Li T, Jahan A and Chiang JY: Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-Jun pathway in human liver cells. Hepatology 43: 1202-1210, 2006.
28. Reinehr R and Häussinger D: Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology 126: 249-262, 2004.
29. Karimian G, Buist-Homan M, Mikus B, Henning RH, FaberKN and Moshage H: Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis. PLoS One 7: e52647, 2012.
30. Mayorga M, Iborra A, Estany S and Martínez P: Protective effect of vitamin E in an animal model of LPS-induced inflammation. Am J Reprod Immunol 52: 356-361, 2004.
31. McGhee JR, Kiyono H, Michalek SM, Babb JL, Rosenstreich DL and Mergenhagen SE: Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS. J Immunol 124: 1603-1611, 1980.
32. Hitchcock PJ, Leive L, Mäkelä PH, Rietschel ET, Strittmatter W and Morrison DC: Lipopolysaccharide nomenclature-past, present, and future. J Bacteriol 166: 699-705, 1986.
33. Lachman E, Pitsoe SB and Gaffin SL: Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. Lancet 1: 981-983, 1984.
34. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al; The HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324: 429-436, 1991.
35. Recknagel P, Gonnert FA, Halilbasic E, et al: Mechanisms and functional consequences of liver failure substantially differ between endotoxaemia and faecal peritonitis in rats. Liver Int 33: 283-293, 2013.